Immunocore Initiates Phase IIa Clinical Trial for IMCgp100 in Melanoma

News   Nov 04, 2013

 
Immunocore Initiates Phase IIa Clinical Trial for IMCgp100 in Melanoma
 
 
 

RELATED ARTICLES

Making Fragrant Fumes

News

Waste oil from orange, tea tree and eucalyptus essential oil production mixed with diesel provides a sweet-smelling biofuel blend with comparable performance to diesel-only fuel.

READ MORE

Novel Method for Testing Vaccine Safety

News

Scientists from the Institut Pasteur, the CNRS and Sanofi Pasteur have recently developed a novel alternative method to animal testing that can be used to verify the safety of vaccines such as the yellow fever vaccine.

READ MORE

New Subtype of Prostate Cancer

News

Researchers led by the University of Michigan Rogel Cancer Center have identified a new subtype of prostate cancer that occurs in about 7 percent of patients with advanced disease.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy